Comerica Bank Has $148,000 Stake in Phibro Animal Health Co. (NASDAQ:PAHC)

Comerica Bank lowered its stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 9.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,059 shares of the company’s stock after selling 741 shares during the period. Comerica Bank’s holdings in Phibro Animal Health were worth $148,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently made changes to their positions in PAHC. Hussman Strategic Advisors Inc. acquired a new position in shares of Phibro Animal Health during the fourth quarter valued at about $2,205,000. Alliancebernstein L.P. raised its holdings in shares of Phibro Animal Health by 357.1% during the fourth quarter. Alliancebernstein L.P. now owns 130,000 shares of the company’s stock valued at $2,730,000 after purchasing an additional 101,560 shares during the period. Prudential Financial Inc. raised its holdings in shares of Phibro Animal Health by 405.8% during the fourth quarter. Prudential Financial Inc. now owns 120,655 shares of the company’s stock valued at $2,534,000 after purchasing an additional 96,800 shares during the period. American Century Companies Inc. raised its holdings in shares of Phibro Animal Health by 18.0% during the fourth quarter. American Century Companies Inc. now owns 635,599 shares of the company’s stock valued at $13,348,000 after purchasing an additional 96,787 shares during the period. Finally, Massachusetts Financial Services Co. MA acquired a new position in shares of Phibro Animal Health during the fourth quarter valued at about $2,020,000. Institutional investors and hedge funds own 99.34% of the company’s stock.

Phibro Animal Health Trading Up 0.7%

PAHC opened at $24.00 on Friday. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. Phibro Animal Health Co. has a fifty-two week low of $16.16 and a fifty-two week high of $26.55. The firm has a market capitalization of $972.82 million, a PE ratio of 50.00, a P/E/G ratio of 0.45 and a beta of 0.62. The company’s 50-day moving average is $20.08 and its 200 day moving average is $21.86.

Phibro Animal Health (NASDAQ:PAHC) last posted its earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share for the quarter, topping analysts’ consensus estimates of $0.52 by $0.11. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. The company had revenue of $347.80 million for the quarter, compared to analyst estimates of $352.41 million. As a group, research analysts predict that Phibro Animal Health Co. will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Wednesday, June 4th will be given a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 2.00%. The ex-dividend date of this dividend is Wednesday, June 4th. Phibro Animal Health’s payout ratio is 61.54%.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. Barclays upped their price objective on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a report on Monday, February 10th. Morgan Stanley upped their price objective on shares of Phibro Animal Health from $20.00 to $21.00 and gave the company an “equal weight” rating in a report on Thursday, May 8th. Finally, StockNews.com upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Friday, May 9th. Two analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $20.00.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.